Description

CJC 1295 with DAC is a growth hormone releasing hormone analogue researched in endocrine and performance related studies. The DAC modification provides a distinct research profile for investigating sustained growth hormone signalling and related biological pathways. Studies explore its relationship with growth hormone activity and IGF 1 signalling, making it relevant to research focused on endocrine regulation and performance biology. Researchers continue to investigate how GHRH analogues interact with hormonal pathways under different experimental conditions. This formulation contains 10mg across 10 vials and is supplied for controlled laboratory research into growth hormone signalling, IGF 1 pathways, endocrine mechanisms, and related biological processes.